SCHEMBL7318796

SCHEMBL7318796

Cc1nc2n(c(=O)c1CCBr)CCCS2

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 10/20 0.51
MAPT P10636 4/20 0.44
ADORA3 P0DMS8 1/20 0.44
XDH P47989 1/20 0.44
LMNA P02545 1/20 0.44
HPGD P15428 4/20 0.43
KDM4E B2RXH2 3/20 0.43
NPC1 O15118 1/20 0.43
GLA P06280 1/20 0.43
RAB9A P51151 1/20 0.43
MAPK1 P28482 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP2C19 P33261 1/20 0.41
HTT P42858 1/20 0.41
HSD17B10 Q99714 2/20 0.39
POLB P06746 1/20 0.39
MEN1 O00255 1/20 0.38
RECQL P46063 1/20 0.38
KMT2A Q03164 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL9747692 0.99 ALDH1A1 (0.50) ALDH1A1MAPTADORA3XDHLMNA
SCHEMBL10922397 0.92 CYP2C19 (0.44) ALDH1A1MAPTXDHLMNAHPGD
Hydrochloric Acid SCHEMBL7291893 0.90 CYP2C19 (0.43) ALDH1A1MAPTXDHLMNAHPGD
Bromide SCHEMBL7142006 0.90 CYP2C19 (0.43) ALDH1A1MAPTXDHLMNAHPGD
SCHEMBL8804527 0.87 ALDH1A1 (0.52) ALDH1A1MAPTADORA3XDHLMNA
SCHEMBL7318656 0.86 ALDH1A1 (0.51) ALDH1A1MAPTADORA3XDHLMNA
SCHEMBL10924999 0.78 CYP2C19 (0.45) ALDH1A1MAPTXDHLMNAHPGD
SCHEMBL3785984 0.77 GAA (0.47) ALDH1A1MAPTXDHLMNAHPGD
SCHEMBL10844976 0.72 DRD2 (0.54) ALDH1A1MAPTLMNAKDM4ENPC1
SCHEMBL10842334 0.72 ALDH1A1 (0.58) ALDH1A1MAPTLMNAHPGDKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4804663-A PSYCHOLOGICAL DISORDERS JANSSEN PHARMACEUTICA N.V. (BE) 1989-02-14 US disclosed
EP-0196132-A2 1,2-Benzisoxazol-3-yl and 1,2-benzisothiazol-3-yl derivatives JANSSEN PHARMACEUTICA N.V. (BE) 1986-10-01 EP disclosed